Poser 1992.
| Methods | Double blind, randomised controlled trial | |
| Participants | 80 patients randomly assigned to 2 different treatment groups. Age and gender data were unavailable. | |
| Interventions | Group 1: monotherapy with low‐molecular weight dextran and placebo Group 2: monotherapy with low‐molecular weight dextran and naftidrofuryl |
|
| Outcomes | Outcome assessment was done by direct comparison of thresholds between groups In this study there was a 70% improvement in the low frequencies in the dextran and naftidrofuryl group, compared to 40% in the dextran monotherapy group. The differences in the higher frequencies were not clear. |
|
| Notes | One patient in the dextran monotherapy group was excluded from the study as he had a allergic reaction on day 4 of the treatment | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Low risk | |
ATP = adenosine triphosphate HAES = hydroxyethyl starch LMW = low‐molecular weight PGE1 = prostaglandin E1 PTA = pure tone audiometry